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ABSTRACT
Ochrobactrum anthropi is a rare nosocomial pathogen that is manifesting itself mostly in immunocompromised 
patients and those with indwelling catheters. Identification of the microorganism is challenging and the ability to 
survive in aquatic surroundings have made it a clinically significant pathogen. Furthermore, the clinical picture of 
O. anthropi infection, is not well described. It may manifest in any form of clinical infections though bacteremia is 
the most common mode of presentation reported in the limited literature. We report here two cases of O. anthropi 
bacteremia presenting in an immunocompetent and an immunocompromised host respectively with different clini-
cal manifestation and response. In view of the highly variable presentation of O.anthropi, a high index of suspicion 
must be given to at risks patients to ensure the timely diagnosis and optimal clinical outcome.  
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INTRODUCTION
Ochrobactrum anthropi is an aerobic, motile, gram 
negative, urease positive, non – lactose fermenting 
bacillus which belongs to the Brucellaceae family (1). 
It was previously known as the “Achromobacter group 
Vd”. The current name is derived from the Greek 
word ochros; this refers to the pale – yellow color of 
the bacterial colonies. It lives in various habitats and 
is an emerging nosocomial pathogen due to its affinity 
for aquatic sources (2). Though perceived to be of low 
virulence, it can cause significant infection primarily in 
immunocompromised hosts, particularly when there is a 
presence of a foreign body or an indwelling catheter. We 
describe here two rare cases of O.anthropi bacteremia 
that we encountered and their clinical courses.  
CASE REPORT
The first case is a 24-year-old Nepalese gentleman, an 
ice factory worker who was previously well and was 
admitted to our intensive care unit for severe dengue 
viral fever complicated with warning signs. Apart from 
fever he had abdominal pain, vomiting, diarrhea and 
gum bleeding. In the emergency department, he showed 
evidence of plasma leakage with reduced air entry and 
evidence of hemoconcentration in his blood results. He 
also had transaminitis from acute liver failure and non-
oliguric acute kidney injury. Upon admission to intensive 
care unit, he was started on piperacillin – tazobactam for 
possible hospital acquired pneumonia as he had spiking 
temperature despite being in the critical phase of dengue. 
After three days of this antibiotic, his blood cultures taken 
on admission grew O.anthropi which was sensitive to 
gentamicin, meropenem, imipenem and tigecycline 
with resistance to ceftazidime, cefepime, piperacillin 
– tazobactam, trimethoprim – sulphamethoxazole 
and polymyxin B. Decision was made to treat this 
opportunistic infection as his fever had not settled on 
the previous antibiotic regime and his infective markers 
(total white cell count and C – reactive protein) were 
noted to be in increasing trends. His antibiotic was 
subsequently changed to meropenem 2g thrice a day 
for a total of fourteen days and he responded clinically 
and became afebrile. However three subsequent blood 
cultures repeated persistently grew O.anthropi cultures 
despite the patient was on the course of meropenem. The 
patient was noted to have a central line that was inserted 
during admission to intensive care unit. The central line 
was removed upon repetitive positive culture results 
but this did not result in resolution of the bacteremia. 
In view of the recurrent positive cultures, he was 
investigated extensively for any specific foci of infection. 
Echocardiogram, bronchoscopy alveolar lavage with 
biopsy and computed topography of thorax, abdomen 
and pelvis turned up to be negative. The subsequent 
positive cultures demonstrated in vitro sensitivity to 
ciprofloxacin in addition to imipenem and meropenem. 
Case was discussed with the infectious disease team 
and decided to attempt a trial of ciprofloxacin. He was 
started on intravenous ciprofloxacin 400mg thrice a 
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group of contracting this opportunistic infection. His 
usual dialysis center monthly bacteriology count and 
endotoxin level for the water distribution system were 
normal. Certificate of analysis for the dialysate was 
performed from an accredited laboratory and it was 
reported as normal as well. There were no other cases 
from the patient’s dialysis center. His infection was 
cleared rather easily despite his immunocompromised 
status, suggesting it behaved more like  a transient 
bacteremia than a true line related sepsis. Notably, both 
patients had not come into contact with each other 
during their stay in the hospital. 
Despite its perceived low virulence, O.anthropi is 
resistant to chloramphemicol and various B – lactams. 
Both cases were detected via Vitek® method by the 
microbiology laboratory and tested for the same 
antibiotics panel. However, for the second case the 
carbapenem results were not released as part of the 
general sensitivity list in order to prevent carbapenem 
misuse. Our first case however demonstrates a possible 
failure with carbapenem treatment as patient did not 
achieve clearance of the organism from his repeated 
blood cultures and required a fluroquinolone which 
eventually proved to be effective. The second case 
also had a different clinical course as he responded to 
fluoroquinolones. It is worth noting that case of clinical 
failure with fluoroquinolone despite showing in vitro 
sensitivity has been reported (5). Also, of note is that 
there have been reports of patients who have improved 
despite having received no antibiotics treatment. 
Mortality risks are relatively low but have mortality 
as high as 50% has been reported (1,5). Nevertheless 
the cause of death is usually not directly related to the 
O.anthropi infection. 
 
CONCLUSION
We have put forth two cases of O.anthropi bacteremia 
that are contrasting in predisposing factors, immune 
status, clinical presentation, sensitivity to carbapenem 
and course of the illness. From these two cases, we 
conclude that O.anthropi is an emerging nosocomial 
pathogen that deserves medical attention due to the 
varied habitat it resides in and its clinical significance in 
immunocompromised patients with indwelling catheters. 
Treatment may or may not be required depending on 
patient’s clinical condition and failure of carbapenem 
though rare, must be kept in mind as a possible sequela. 
In view that majority of our patients fall into the at-risk 
group for this infection, this microorganism should be 
kept in consideration when treating these patients. In 
addition, infection control measures should be in place 
to prevent the spread of this organism. 
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